Trial intelligence / Profile preview

PXVX0200 Immunogenicity in Malian Adults

NCT02145377Phase 2Completed

Sponsor
University of Maryland, Baltimore
Start
Jul 2014
Primary completion
Mar 2015
Modality
Live Biotherapeutic Products, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of cholera vaccine, live, oral in cholera, sponsored by University of Maryland, Baltimore. Started Jul 2014; status: completed.

02

Drugs

cholera vaccine, live, oral
03

Conditions

cholera

Beyond the preview

Go deeper on NCT02145377.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02145377.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call